Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Muscle Invasive Bladder Cancer × AZD 6244 × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neurofibromatosis 1 9 Neurofibroma, Plexiform 6 Triple Negative Breast Neoplasms 1 Sarcoma 1 Primary Myelofibrosis 1 Pain 1 Neurofibrosarcoma 1 Neoplasms 1 Muscle Invasive Bladder Cancer 1 Melanoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1 Advanced Non Small Cell Lung Cancer 1

Interventions

vistusertib 1 olaparib 1 durvalumab 1 danvatirsen 1 adavosertib 1 AZD4547 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02546661 2025-12-29

BISCAY

AstraZeneca

Phase 1 Active not recruiting

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡